MIAMI BEACH, Fla., July 18, 2011 /PRNewswire/ -- Biotech pioneer Divine Skin Inc. (DSKX) announced a partnership with India's largest pharmaceutical company, Ranbaxy Laboratories, to sell the DS Laboratories line of topical hair-growth treatments through its massive distribution pipeline.
With its strong presence in the top pharmaceutical markets, Ranbaxy offers Divine Skin an expanded global distribution network. With its innovative line of hair-growth products, Divine Skin offers Ranbaxy several topical formulations proven to work both at the vertex of the scalp and at the hairline, unlike other brands.
"This agreement is a game changer for Divine Skin investors," declared CEO Daniel Khesin. "Ranbaxy is certainly has the resources to develop its own hair-growth brand, yet it has chosen to partner with Divine Skin. It's a powerful endorsement of our cutting-edge technologies. Now our challenge is to accelerate production to keep up with sales."
The DS Laboratories brand expands the treatment options available for men and women suffering hair loss and thinning. Products include the Spectral line of leave-in treatments and the Revita line of shampoo, conditioner, and eyelash treatment.The comprehensive formulas blend various combinations of minoxidil, finasteride, Aminexil, peptides, procyanidin, stem cells, spin traps, dihydrotestosterone inhibitors, and other powerful ingredients. A proprietary Nanosome delivery system encapsulates active compounds for deeper penetration, longer persistence, and greater efficacy. About Ranbaxy Ranbaxy Laboratories is a top-20 pharmaceutical company manufacturing a wide range of high-quality generic medications. Headquartered near New Delhi, the company has global revenue of $1.9 billion, customers in 125 countries, presence in 46 countries, and manufacturing facilities in seven countries. Already a manufacturing and distribution powerhouse, the company focuses on research and development of innovative drugs for its future growth ( www.Ranbaxy.com). About Divine Skin Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV